Patents Assigned to The European Community, as Represented by the European Commision
  • Radioimmunoconjugates for targeted alpha therapy
    Patent number: 7632927
    Abstract: A radioimmunoconjugate for targeted alpha therapy comprises an alpha-emitter (e.g. Bi-213) linked to the monoclonal antibody C595. This radioimmunoconjugate is widely applicable in cancer therapy and is particularly efficient for treatment of pancreatic and prostate cancer, as well as for breast and ovarian cancer.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: December 15, 2009
    Assignee: The European Community, as Represented by the European Commision
    Inventors: Barry Allen, Syed Rizvi, Yong Li, Chang Fa On